|
CCDC90B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62547753035369E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.29439800492059E-11 |
| Normal-vs-Stage2 |
1.40230005385433E-09 |
| Normal-vs-Stage3 |
1.99840144432528E-15 |
| Normal-vs-Stage4 |
1.63091762317435E-12 |
| Stage1-vs-Stage2 |
2.197400E-01 |
| Stage1-vs-Stage3 |
1.319240E-03 |
| Stage1-vs-Stage4 |
2.996700E-04 |
| Stage2-vs-Stage3 |
2.784600E-01 |
| Stage2-vs-Stage4 |
4.935800E-02 |
| Stage3-vs-Stage4 |
2.650800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99840144432528E-15 |
| Normal-vs-AfricanAmerican |
4.53109999998258E-06 |
| Normal-vs-Asian |
3.53130003016844E-09 |
| Caucasian-vs-AfricanAmerican |
7.862400E-01 |
| Caucasian-vs-Asian |
7.052000E-01 |
| AfricanAmerican-vs-Asian |
9.956200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55431223447522E-15 |
| Normal-vs-Female |
1.74182890333441E-12 |
| Male-vs-Female |
3.397100E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.6550997218352E-10 |
| Normal-vs-Age(41-60Yrs) |
1.12465592394528E-13 |
| Normal-vs-Age(61-80Yrs) |
1.62503344114384E-12 |
| Normal-vs-Age(81-100Yrs) |
3.51729999999995E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.178810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.819400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.219050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.062100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.691400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.045800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.983600E-02 |
| Classical-VS-Follicular |
7.558400E-02 |
| Classical-VS-Other |
8.446400E-01 |
| Classical-VS-Normal |
1.93145499594038E-12 |
| Tall-VS-Follicular |
5.423600E-01 |
| Tall-VS-Other |
6.214200E-01 |
| Tall-VS-Normal |
3.14649972743553E-10 |
| Follicular-VS-Other |
7.310000E-01 |
| Follicular-VS-Normal |
4.44609904448612E-11 |
| Other-VS-Normal |
4.781000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14113188185183E-14 |
| Normal-vs-N1 |
6.21130036293494E-10 |
| N0-vs-N1 |
6.731000E-01 |
|
|
